Prolonged survival of 2 years or longer for patients with disseminated melanoma

Prolonged survival of 2 years or longer for patients with disseminated melanoma
复制标题

DOI：
10.1002/(sici)1097-0142(19970615)79:12
复制
发表时间：
1997-06
期刊：
Cancer
影响因子：
6.2
通讯作者：
C. Brand;U. Ellwanger;W. Stroebel;F. Meier;B. Schlagenhauff;G. Rassner;C. Garbe
C. Brand;U. Ellwanger;W. Stroebel;F. Meier;B. Schlagenhauff;G. Rassner;C. Garbe
中科院分区：
医学1区
文献类型：
--
作者：
C. Brand;U. Ellwanger;W. Stroebel;F. Meier;B. Schlagenhauff;G. Rassner;C. Garbe

文献摘要

被引文献

相似文献

一旦黑色素瘤转移到远处，预后通常很差，总体中位生存期为6 - 8个月。长期生存是非常罕见的，仍然有争议的预后意义的治疗方式。本研究的目的是确定与IV期黑色素瘤相关的重要预后因素。
Once melanoma has metastasized to distant sites, the prognosis is usually poor, showing an overall median survival of 6‐8 months. Long term survival is extremely rare, and there is still controversy concerning the prognostic significance of therapeutic modalities. The aim of the current study was to identify important prognostic factors associated with Stage IV melanoma.